CGON Form 3: Director Christina Rossi lists zero beneficial holdings

Rhea-AI Filing Summary

CG Oncology, Inc. (CGON) director Christina Rossi has filed an initial insider ownership report indicating that she currently beneficially owns no securities of the company. Both the non-derivative and derivative security tables show no holdings, and the explanation section explicitly states that no securities are beneficially owned.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rossi Christina

(Last) (First) (Middle)

C/O CG ONCOLOGY, INC.

400 SPECTRUM CENTER DRIVE, SUITE 2040

(Street)

IRVINE CA 92618

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/24/2025

3. Issuer Name and Ticker or Trading Symbol
CG Oncology, Inc. [ CGON ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Joshua F. Patterson, Attorney-in-Fact for Christina Rossi	11/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the CG Oncology (CGON) Form 3 filing report for Christina Rossi?

The Form 3 shows that director Christina Rossi has reported beneficial ownership of no CG Oncology securities at the time of the filing.

Does Christina Rossi own any CGON common stock according to this Form 3?

No. The non-derivative securities table for CG Oncology, Inc. (CGON) shows no shares beneficially owned by Christina Rossi.

Are there any options or other derivative securities reported for Christina Rossi in CGON?

No. The derivative securities table for CG Oncology (CGON) is effectively empty, and the explanation confirms no securities are beneficially owned.

What is Christina Rossi’s role at CG Oncology (CGON) in this filing?

Christina Rossi is identified as a director of CG Oncology, Inc. (CGON) in the Form 3 filing.

Why is this CG Oncology (CGON) Form 3 important for investors?

Form 3 provides a baseline of initial insider ownership. In this case, it shows that director Christina Rossi starts with no reported CGON holdings.